8PXM

N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH (1R,1'R)-7,7'-(pentane-1,5-diylbis(oxy))bis(1,3-dimethyl-1,3-dihydro-2H-benzo[d]azepin-2-one)

Summary for 8PXM

• Entry DOI: 10.2210/pdb8pxm/pdb
• Descriptor: Bromodomain-containing protein 4, (1R)-7-[5-[[(1R)-1,3-dimethyl-2-oxidanylidene-1H-3-benzazepin-7-yl]oxy]pentoxy]-1,3-dimethyl-1H-3-benzazepin-2-one, 1,2-ETHANEDIOL, ... (4 entities in total)
• Functional Keywords: inhibitor, histone, epigenetic reader, bromodomain, brd4, bromodomain containing protein 4, antagonist, transcription
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 2
• Total formula weight: 30735.42

Authors

Chung, C.W. (deposition date: 2023-07-23, release date: 2023-10-04)

• Primary citation: Bamborough, P.,Chung, C.W.,Goodwin, N.C.,Mitchell, D.J.,Neipp, C.E.,Phillipou, A.,Preston, A.,Prinjha, R.K.,Soden, P.E.,Watson, R.J.,Demont, E.H.; Design and Characterization of 1,3-Dihydro-2 H -benzo[ d ]azepin-2-ones as Rule-of-5 Compliant Bivalent BET Inhibitors.; Acs Med.Chem.Lett., 14:1231-1236, 2023; PubMed: 37736196; DOI: 10.1021/acsmedchemlett.3c00242

Experimental method

X-RAY DIFFRACTION (2.378 Å)